Cargando…

Synthesis and Pharmacological Characterization of Metronidazole-Oxadiazole Derivatives

BACKGROUND: The use of antibiotics with or without prescription is increasing worldwide. With certain limitations, metronidazole (MTZ) is extensively used as an antibacterial and antiparasitic drug. Derivatives of 1,2,4-oxadiazole (ODZ) are used to modify the chemical structure of drugs. The present...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohammed, Mohsin, Haj, Nadia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Shiraz University of Medical Sciences 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9989235/
https://www.ncbi.nlm.nih.gov/pubmed/36895463
http://dx.doi.org/10.30476/IJMS.2022.95534.2691
_version_ 1784901725497327616
author Mohammed, Mohsin
Haj, Nadia
author_facet Mohammed, Mohsin
Haj, Nadia
author_sort Mohammed, Mohsin
collection PubMed
description BACKGROUND: The use of antibiotics with or without prescription is increasing worldwide. With certain limitations, metronidazole (MTZ) is extensively used as an antibacterial and antiparasitic drug. Derivatives of 1,2,4-oxadiazole (ODZ) are used to modify the chemical structure of drugs. The present study aimed to synthesize new MTZ-ODZ derivatives that could potentially lead to new medications. METHODS: The reaction of MTZ with ethyl chloroacetate and potassium carbonate anhydrous was used to produce compound 7. This compound was treated with hydrazine hydrate in methanol to obtain compound 8. Carbon disulfide and potassium hydroxide were then added to obtain compound 9, which was then mixed with various α-haloketones to obtain compounds 10a to 10f. Subsequently, the structures of the new MTZ-ODZ derivatives were determined. RESULTS: All new compounds exhibited excellent activity against all tested organisms. The synthesized compounds showed a significant radical scavenging activity. The IC(50) value for compounds 10a, 10b, 10c, 10d, 10e, and 10f was 70.42±0.15, 70.52±0.54, 85.21±0.85, 80.10±0.46, 82.52±0.13, and 70.45±0.12 g/mL, respectively. In terms of antigiardial activity, the IC(50) value for compounds 10a,10b, 10c, and 10d ranged from 1.31±0.11 µM to 2.26±0.49 µM. In contrast, the IC(50) for MTZ was 3.71±0.27 µM. Compound 10f showed the highest antigiardial activity with an IC(50) value of 0.88±0.52 µM. CONCLUSION: Most of the MTZ-ODZ derivatives showed high radical scavenging activity in the benzene ring due to the activation of certain groups, such as OCH(3), NO(2), and OH. The results suggest that the newly synthesized compounds could be used as an antiparasitic drug.
format Online
Article
Text
id pubmed-9989235
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Shiraz University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-99892352023-03-08 Synthesis and Pharmacological Characterization of Metronidazole-Oxadiazole Derivatives Mohammed, Mohsin Haj, Nadia Iran J Med Sci Original Article BACKGROUND: The use of antibiotics with or without prescription is increasing worldwide. With certain limitations, metronidazole (MTZ) is extensively used as an antibacterial and antiparasitic drug. Derivatives of 1,2,4-oxadiazole (ODZ) are used to modify the chemical structure of drugs. The present study aimed to synthesize new MTZ-ODZ derivatives that could potentially lead to new medications. METHODS: The reaction of MTZ with ethyl chloroacetate and potassium carbonate anhydrous was used to produce compound 7. This compound was treated with hydrazine hydrate in methanol to obtain compound 8. Carbon disulfide and potassium hydroxide were then added to obtain compound 9, which was then mixed with various α-haloketones to obtain compounds 10a to 10f. Subsequently, the structures of the new MTZ-ODZ derivatives were determined. RESULTS: All new compounds exhibited excellent activity against all tested organisms. The synthesized compounds showed a significant radical scavenging activity. The IC(50) value for compounds 10a, 10b, 10c, 10d, 10e, and 10f was 70.42±0.15, 70.52±0.54, 85.21±0.85, 80.10±0.46, 82.52±0.13, and 70.45±0.12 g/mL, respectively. In terms of antigiardial activity, the IC(50) value for compounds 10a,10b, 10c, and 10d ranged from 1.31±0.11 µM to 2.26±0.49 µM. In contrast, the IC(50) for MTZ was 3.71±0.27 µM. Compound 10f showed the highest antigiardial activity with an IC(50) value of 0.88±0.52 µM. CONCLUSION: Most of the MTZ-ODZ derivatives showed high radical scavenging activity in the benzene ring due to the activation of certain groups, such as OCH(3), NO(2), and OH. The results suggest that the newly synthesized compounds could be used as an antiparasitic drug. Shiraz University of Medical Sciences 2023-03 /pmc/articles/PMC9989235/ /pubmed/36895463 http://dx.doi.org/10.30476/IJMS.2022.95534.2691 Text en Copyright: © Iranian Journal of Medical Sciences https://creativecommons.org/licenses/by-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-NoDerivatives 4.0 International License. This license allows reusers to copy and distribute the material in any medium or format in unadapted form only, and only so long as attribution is given to the creator. The license allows for commercial use.
spellingShingle Original Article
Mohammed, Mohsin
Haj, Nadia
Synthesis and Pharmacological Characterization of Metronidazole-Oxadiazole Derivatives
title Synthesis and Pharmacological Characterization of Metronidazole-Oxadiazole Derivatives
title_full Synthesis and Pharmacological Characterization of Metronidazole-Oxadiazole Derivatives
title_fullStr Synthesis and Pharmacological Characterization of Metronidazole-Oxadiazole Derivatives
title_full_unstemmed Synthesis and Pharmacological Characterization of Metronidazole-Oxadiazole Derivatives
title_short Synthesis and Pharmacological Characterization of Metronidazole-Oxadiazole Derivatives
title_sort synthesis and pharmacological characterization of metronidazole-oxadiazole derivatives
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9989235/
https://www.ncbi.nlm.nih.gov/pubmed/36895463
http://dx.doi.org/10.30476/IJMS.2022.95534.2691
work_keys_str_mv AT mohammedmohsin synthesisandpharmacologicalcharacterizationofmetronidazoleoxadiazolederivatives
AT hajnadia synthesisandpharmacologicalcharacterizationofmetronidazoleoxadiazolederivatives